Skip to main content
Clinical Trials/NCT06593665
NCT06593665
Recruiting
Phase 3

Randomized Prospective Study Comparing Intrathecal Morphine vs Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection (RPLND)

Indiana University2 sites in 1 country142 target enrollmentSeptember 10, 2024

Overview

Phase
Phase 3
Intervention
Inrathecal Morphine
Conditions
Testicular Cancer
Sponsor
Indiana University
Enrollment
142
Locations
2
Primary Endpoint
IV morphine equivalent (MME)
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at different postoperative time intervals.

Detailed Description

In this study, investigators aim to compare intravenous methadone combined with standard multimodal analgesia and surgical infiltration of local anesthesia to intrathecal duramorph with standard multimodal analgesia and surgical infiltration of local anesthesia. In this single blinded prospective randomized control trial, investigators hypothesize that intravenous methadone will provide a significant reduction in patient opioid consumption when compared to intrathecal opioid analgesia in the first 24 hours in patients who undergo PC/RPLND.

Registry
clinicaltrials.gov
Start Date
September 10, 2024
End Date
December 31, 2026
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kevin Michael Backfish-White, MD

Dept. of Anesthesiology, Asst. Professor

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing a virgin (chemotherapy has not been used) or post- chemotherapy retroperitoneal lymph node dissection for primary testicular cancer at IU Health AAHC
  • ASA Class 1, 2, 3
  • Age 18 to 80 years; Male
  • BMI less than 50kg/m2

Exclusion Criteria

  • Any contraindication for neuraxial analgesia
  • Patient on home methadone at any dose
  • Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.
  • Known true allergy to the study medications (morphine, bupivacaine, acetaminophen, methadone)
  • Any history of substance abuse in the past 6 months which would include heroin or any other illegal street drugs
  • End stage liver disease, end stage renal disease
  • Patient staying intubated after surgery
  • Patient (home dose) taking more than 30mg PO morphine equivalent (PME) per day
  • Any additional surgical procedures to the patient with a different surgical incision compared to the standard laparotomy for the RPLND procedure, i.e. thoracic tumor reduction

Arms & Interventions

Intrathecal Morphine

Intrathecal preservative free morphine (duramorph) 200 mcg with 7.5mg of hyperbaric bupivacaine placed by a spinal needle prior to induction of general anesthesia (n=71)

Intervention: Inrathecal Morphine

Intravenous Methadone

Intravenous methadone dosed at 0.2 mg/kg Ideal Body weight up to a maximum dose of 20mg, rounded to the nearest milligram, for all patients given during the induction of general anesthesia (n=71)

Intervention: Intravenous Methadone

Outcomes

Primary Outcomes

IV morphine equivalent (MME)

Time Frame: First 24 hours postoperative

Cumulative Milligrams of morphine equivalent (MME) consumption

Secondary Outcomes

  • Opioid consumption(24 hours after arrival time to post anesthesia care unit)
  • Opioid side effect-Nausea(after arrival time to post anesthesia care unit until 24 hours/completion of study)
  • Opioid side effects-Vomiting(after arrival time to post anesthesia care unit until 24 hours/completion of study)
  • Opioid side effects-Pruritis(after arrival time to post anesthesia care unit until 24 hours/completion of study)
  • Adverse Events(after arrival time to post anesthesia care unit until 24 hours/completion of study)
  • Opioid side effects-Respiratory Depression(after arrival time to post anesthesia care unit until 24 hours/completion of study)
  • Pain Scores(12 hours after arrival time to post anesthesia care unit)
  • Opioid consumption(1 hour after arrival time to post anesthesia care unit)
  • Opioid consumption(12 hours after arrival time to post anesthesia care unit)
  • Pain Scores(24 hours after arrival time to post anesthesia care unit)

Study Sites (2)

Loading locations...

Similar Trials